Fairmount Healthcare Fund II GP, Director: Viridian Therapeutics, Inc.\DE VRDN Buy · Filed 24/09/17

Trade details

Type: Insider buy
Amount: $30,000,000
Shares · price: 1,600,000 sh · $18.75 a share
Held after: 3,445,813 sh
Stock: Viridian Therapeutics, Inc.\DE VRDN
Person: Fairmount Healthcare Fund II GPDirector
Trade date: 24/09/13
Filed: 24/09/17
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +86.7%

Viridian Therapeutics, Inc.\DE trades, last 26 weeks

What else happened in Viridian Therapeutics, Inc.\DE around then

Filed or reported within 30 days of the trade day · 24/08/14~24/10/13

Fairmount Healthcare Fund II GP's recent trades

Fairmount Healthcare Fund II GPDirector
BuyViridian Therapeutics, Inc.\DE
Buy
Viridian Therapeutics, Inc.\DE
VRDN
$20M
1,176,470 sh
$20M
Filed 05/13
Traded 05/11
Fairmount Healthcare Fund II GPDirector
BuyViridian Therapeutics, Inc.\DE
Buy
Viridian Therapeutics, Inc.\DE
VRDN
$10M
454,545 sh
$10M
Filed 25/10/27
Traded 25/10/23
Fairmount Healthcare Fund II GPDirector
BuyViridian Therapeutics, Inc.\DE
Buy
Viridian Therapeutics, Inc.\DE
VRDN
$10M
476,190 sh
$10M
Filed 24/01/24
Traded 24/01/22